Candel Therapeutics (CADL)

• Market cap: $254M
• 1 day: 3.36%
• 5 days: 3.59%
• 1 month: -14.44%
• 3 months: -22.48%
• 6 months: -17.5%
• Year to date: -48.61%
• 1 year: 0%
• 5 years: -34%
• 10 years: -34%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38